ONWARDS 11 Study

Type 1 Diabetes (T1D)

This study is evaluating and investigational once-weekly basal (long-acting) insulin (insulin ICODEC) in combination with a rapid-acting (mealtime) insulin in people with T1D who are not achieving glucose targets using a multiple daily injection (MDI) insulin regimen.

This study is investigating a once-weekly long-acting insulin (insulin icodec) compared to daily insulin glargine, both used in combination with a rapid-acting (mealtime) insulin (insulin aspart), in adults living with type 1 diabetes being treated with multiple daily insulin (MDI) injections.